pubmed-article:18827605 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C1122962 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:18827605 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:18827605 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:18827605 | pubmed:dateCreated | 2008-10-1 | lld:pubmed |
pubmed-article:18827605 | pubmed:abstractText | Epidermal growth factor receptor (EGFR) gene intron 1 contains a polymorphic single sequence dinucleotide repeat (CA)n whose length has been found to inversely correlate with transcriptional activity. This study was designed to assess the role of (CA)n polymorphism in predicting the outcome of gefitinib treatment in advanced non-small cell lung cancer (NSCLC). | lld:pubmed |
pubmed-article:18827605 | pubmed:language | eng | lld:pubmed |
pubmed-article:18827605 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18827605 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18827605 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18827605 | pubmed:issn | 1556-1380 | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:BozzettiCecil... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:FranciosiVitt... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:PetroniniPier... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:RindiGuidoG | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:AlfieriRobert... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:CavazzoniAndr... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:GoldoniMatteo... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:ArdizzoniAndr... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:BoniLucaL | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:CamisaRoberta... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:De... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:MozzoniPaolaP | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:LopreviteMaur... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:TiseoMarcello... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:CapellettiMar... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:GalettiMaricl... | lld:pubmed |
pubmed-article:18827605 | pubmed:author | pubmed-author:BortesiBeatri... | lld:pubmed |
pubmed-article:18827605 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18827605 | pubmed:volume | 3 | lld:pubmed |
pubmed-article:18827605 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18827605 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18827605 | pubmed:pagination | 1104-11 | lld:pubmed |
pubmed-article:18827605 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:meshHeading | pubmed-meshheading:18827605... | lld:pubmed |
pubmed-article:18827605 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18827605 | pubmed:articleTitle | Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer. | lld:pubmed |
pubmed-article:18827605 | pubmed:affiliation | Division of Medical Oncology, University Hospital of Parma, Italy. mtiseo@ao.pr.it | lld:pubmed |
pubmed-article:18827605 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18827605 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1956 | entrezgene:pubmed | pubmed-article:18827605 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18827605 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18827605 | lld:entrezgene |
lhgdn:association:6601 | lhgdn:found_in | pubmed-article:18827605 | lld:lhgdn |